Recombinant Glucocerebrosidase (Imiglucerase) as a Therapy for Gaucher Disease

Author： Pastores Gregory M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.24, Iss.1, 2010-02, pp. : 41-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progressive decline of glucocerebrosidase in aging and Parkinson's disease

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 4, 2015-04 ,pp. : 433-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variants associated with Gaucher disease in multiple system atrophy

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 4, 2015-04 ,pp. : 417-426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alglucerase: Practical Guidance on Appropriate Dosage and Administration in Patients with Gaucher Disease

By Hollak C.E.M.  

BioDrugs, Vol. 9, Iss. 1, 1998-01 ,pp. : 11-23

Adis International

Access to resources Recommend Favorite

Atopic Dermatitis: The Role of Recombinant Interferon- Therapy

By Chang T.T.   Stevens S.R.  

American Journal of Clinical Dermatology, Vol. 3, Iss. 3, 2002-03 ,pp. : 175-183

Adis International

Access to resources Recommend Favorite

Prevalence of Joint Disease in Patients with Psoriasis: Implications for Therapy

By Zachariae H.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 7, 2003-01 ,pp. : 441-447

Adis International

Access to resources Recommend Favorite